Doctor profile · Federal record
Dr. Alexa Hetzel, PA-C
Physician Assistant · East Windsor, NJ
- NPI 1851887301
- Accepts Medicare
- MIPS 94.1 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
59 One Mile RD Ext
East Windsor, NJ 085202505
(609) 443-4500
Credentials & registration
- NPI registered
- July 2018 — 8 yrs on file
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- New Jersey #25MP00479400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851887301. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,977
Distinct HCPCS
10
Medicare allowed
$432,591
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3245 |
Injection, tildrakizumab, 1 mg | 2,500 | 12 | $138 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 484 | 89 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 201 | 169 | $83 | |
17000 |
Destruction of precancer skin growth, 1 growth | 149 | 120 | $47 | |
11102 |
Biopsy of related skin growth, first growth | 146 | 124 | $87 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 138 | 101 | $117 | |
17110 |
Destruction of skin growth, 1-14 growths | 93 | 79 | $101 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 50 | 45 | $52 | |
96372 |
Injection of drug or substance under skin or into muscle | 46 | 19 | $13 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 41 | 37 | $160 |
In context: peer comparison
Among 3 peers in East Windsor Physician Assistant, average services per provider: 194. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$119,687
Transactions
391
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 69 | $26,368.27 | |
| Lilly USA, LLC | 70 | $21,814.67 | |
| Ucb, INC. | 29 | $20,109.94 | |
| Abbvie INC. | 48 | $16,299.46 | |
| E.R. Squibb & Sons, L.L.C. | 28 | $8,489.92 | |
| Arcutis Biotherapeutics, INC. | 21 | $7,924.53 | |
| Genzyme Corporation | 14 | $7,294.44 | |
| Incyte Corporation | 28 | $5,274.81 | |
| Regeneron Healthcare Solutions, INC. | 14 | $1,800.38 | |
| Leo Pharma INC. | 9 | $1,531.69 | |
| Pfizer INC. | 25 | $1,000.42 | |
| Dermavant Sciences, INC. | 8 | $933.17 | |
| Novartis Pharmaceuticals Corporation | 11 | $256.07 | |
| Sun Pharmaceutical Industries INC. | 7 | $199.54 | |
| Amgen INC. | 10 | $152.08 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
300
Patients
121
Total drug cost
$278,077
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 72 | 43 | $990 |
| Clobetasol Propionate | Generic | 52 | 29 | $2,949 |
| Ketoconazole | Generic | 39 | 24 | $929 |
| Clindamycin Phosphate | Generic | 22 | 0 | $588 |
| Mupirocin | Generic | 19 | 14 | $99 |
| Dupixent Pen (Dupilumab) | Brand | 17 | 0 | $65,332 |
| Tretinoin | Generic | 16 | 11 | $1,129 |
| Dupixent Syringe (Dupilumab) | Brand | 14 | 0 | $48,931 |
| Doxycycline Hyclate | Generic | 13 | 0 | $333 |
| Enbrel Sureclick (Etanercept) | Brand | 13 | 0 | $87,426 |
Frequently asked questions
What is Dr. Alexa Hetzel's medical specialty?
Dr. Alexa Hetzel practices Physician Assistant in East Windsor, NJ.
Where does Dr. Alexa Hetzel practice?
Dr. Alexa Hetzel practices at 59 One Mile RD Ext, East Windsor, NJ 085202505. Office phone: 6094434500.
What is Dr. Alexa Hetzel's NPI?
Dr. Alexa Hetzel's National Provider Identifier (NPI) is 1851887301, issued by NPPES.
Does Dr. Alexa Hetzel accept Medicare assignment?
Yes. Dr. Alexa Hetzel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alexa Hetzel commonly perform?
Top Medicare-reported procedures in 2023: Injection, tildrakizumab, 1 mg (HCPCS J3245); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.